FECZKO JOSEPH M 4
4 · ChemoCentryx, Inc. · Filed Jan 25, 2022
Insider Transaction Report
Form 4
FECZKO JOSEPH M
Director
Transactions
- Exercise/Conversion
Common Stock
2022-01-21$15.90/sh+25,000$397,500→ 135,627 total - Exercise/Conversion
Common Stock
2022-01-21$14.42/sh+12,500$180,250→ 148,127 total - Exercise/Conversion
Stock Option (right to buy)
2022-01-21−25,000→ 0 totalExercise: $15.90Exp: 2022-04-25→ Common Stock (25,000 underlying) - Exercise/Conversion
Stock Option (right to buy)
2022-01-21−12,500→ 0 totalExercise: $14.42Exp: 2022-06-22→ Common Stock (12,500 underlying)
Footnotes (2)
- [F1]As of January 21, 2022, and prior to this transaction, the exercised options were fully vested.
- [F2]Not applicable.